Summary
Background With the COVID-19 pandemic infecting millions of people, large- scale quarantine policies have been enacted across the globe. Understanding how to maximize the effectiveness of these policies while mitigating economic damage is essential. We develop a mathematical model to assess the impact of quarantine measures on deaths, hospitalizations, and economic output.
Methods We expand the SEIR model to simulate the spread of COVID-19. We incorporate the effects of quarantine policies and segment the population based on health risk and economic vulnerability. Using our model, we simulate a baseline scenario that leaves the current quarantine restrictions in place. We then simulate a rapid relaxation of the quarantine restrictions for non-seniors shortly after the outbreak is contained. Finally, we gradually relax the quarantine restrictions for the young individuals, while maintaining extremely strict restrictions for seniors.
Findings In the baseline scenario, we find that over 76 weeks in a population of 330 million, there are 32,131 deaths among those under 60 and 175,775 deaths among those over 60, there is a peak of 189,136 hospitalizations, and the economy shrinks by 0.56%. In the scenario where quarantine is quickly lifted a second outbreak takes place. Overall, there are 242,869 deaths among those under 60, 545,946 deaths among those over 60, a peak of 4,363,654 hospitalizations, and the economy expands by 5.2%. In the scenario where quarantine policies are progressively relaxed for the young individuals, there are 33,750 deaths among those under 60, 187,993 deaths among those over 60, a peak of 189,136 hospitalizations, and the economy expands by 4%.
Interpretation Strict restrictions on seniors combined with very gradual lifting of quarantine for the general population results in a limited number of deaths and lesser economic damage. We recommend this strategy and lowering contagiousness to control the pandemic while making quarantine economically viable.
Funding No funding to declare.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No specific funding was used for this work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
3
Blogs/Media
Author Videos